The British Journal of Psychiatry (1965) 111: 659-674. doi: 10.1192/bjp.111.477.659
© 1965 The Royal College of Psychiatrists
This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by CARNEY, M. W. P.
Right arrow Articles by GARSIDE, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CARNEY, M. W. P.
Right arrow Articles by GARSIDE, R. F.

The Diagnosis of Depressive Syndromes and the Prediction of E.C.T. Response

M. W. P. CARNEY M.D., M.R.C.P.I., D.P.M.1, M. ROTH M.D., F.R.C.P., D.P.M.2, and R. F. GARSIDE B.Sc.3

1 Consultant Psychiatrist, Blackpool and Fylde Hospital Group and Lancaster Moor Hospital
2 Professor of Psychological Medicine, University of Newcastle upon Tyne
3 Senior Lecturer in Applied Psychology, University of Newcastle upon Tyne

An investigation of 129 in-patient depressives treated with E.C.T. is presented. All were followed up to 3 months, and 108 to 6 months. Initially all were scored for the presence or absence of 35 features considered to discriminate between endogenous and neurotic depressions. Diagnoses were allocated before or early during treatment. Patients were rated at the termination of E.C.T. at 3 months and at 6 months, on a four-point scale. At 3 months, only 12 out of 63 neurotic depressives were found to have responded well to E.C.T., whereas out of 53 endogenous depressives had done so; the corresponding figures for 6 months were 8 out of 53 and 34 out of 44.

A factor analysis of the features produced three significant factors, a bipolar factor corresponding to the distinction between endogenous and neurotic depression, a general factor with high loadings for many features common to all the depressive cases studied and, probably, a paranoid psychotic factor. The bipolar factor closely resembles that extracted in a previous investigation (Kiloh and Garside, 1963) and supports the hypothesis that these are two distinct depressive populations. Among features with high positive loadings on the first factor, and thus corresponding to a diagnosis of endogenous depression, were adequate premorbid personality, absence of adequate psychogenic factors in relation to illness, a distinct quality to the depression, weight loss, pyknic body build, occurrence of previous depressive episode, early morning awakening, depressive psychomotor activity, nihilistic, somatic and paranoid delusions, and ideas of guilt. Among features with a negative loading corresponding to a diagnosis of neurotic depression were anxiety, aggravation of symptoms in the evening, self-pity, a tendency to blame others, and hysterical features.

By means of multiple regression analysis, three series of 18 weighted coefficients for the differential diagnosis between the two varieties of depression and for the prediction of E.C.T. response at 3 and 6 months were calculated. The multiple correlations between the summed features on the one hand and diagnosis and outcome at 3 and 6 months on the other were 0.91, 0.72 and 0.74 respectively. It was thought that E.C.T. response could be better predicted by the direct use of the weights for E.C.T. response than from the diagnostic weights alone. The weights based on the 18 features were complex, and therefore a further table was constructed giving simplified weights based on ten features of diagnosis and ten features for prediction of outcome of treatment with E.C.T. after 6 months.

Submitted on December 24, 1964




This article has been cited by other articles:


Home page
Br. J. PsychiatryHome page
V. NAVARRO, C. GASTO, F. LOMENA, X. TORRES, J. J. MATEOS, M. J. PORTELLA, G. MASANA, and T. MARCOS
Prognostic value of frontal functional neuroimaging in late-onset severe major depression
The British Journal of Psychiatry, April 1, 2004; 184(4): 306 - 311.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
R. J. PORTER, P. GALLAGHER, J. M. THOMPSON, and A. H. YOUNG
Neurocognitive impairment in drug-free patients with major depressive disorder
The British Journal of Psychiatry, March 1, 2003; 182(3): 214 - 220.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
R. T. Mulder, R. J. Porter, and P. R. Joyce
The prolactin response to fenfluramine in depression: effects of melancholia and baseline cortisol
J Psychopharmacol, January 1, 2003; 17(1): 97 - 102.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
J. D. Amsterdam
Selective serotonin reuptake inhibitor efficacy in severe and melancholic depression
J Psychopharmacol, January 1, 1998; 12(4_suppl): S99 - S111.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
R. T. Rubin, E. K. Heist, S. S. McGeoy, K. Hanada, and I. M Lesser
Neuroendocrine Aspects of Primary Endogenous Depression: XI. Serum Melatonin Measures in Patients and Matched Control Subjects
Arch Gen Psychiatry, July 1, 1992; 49(7): 558 - 567.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
C. F. Duggan, A. S. Lee, and R. M. Murray
Do Different Subtypes of Hospitalized Depressives Have Different Long-term Outcomes?
Arch Gen Psychiatry, April 1, 1991; 48(4): 308 - 312.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
P. R. Joyce and E. S. Paykel
Predictors of Drug Response in Depression
Arch Gen Psychiatry, January 1, 1989; 46(1): 89 - 99.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
J. R. T. Davidson, E. L. Giller, S. Zisook, and J. E. Overall
An Efficacy Study of Isocarboxazid and Placebo in Depression, and Its Relationship to Depressive Nosology
Arch Gen Psychiatry, February 1, 1988; 45(2): 120 - 127.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
D. Healy
The comparative psychopathology of affective disorders in animals and humans
J Psychopharmacol, January 1, 1987; 1(3): 193 - 210.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
M. Zimmerman, W. Coryell, B. Pfohl, and D. Stangl
The Validity of Four Definitions of Endogenous Depression: II. Clinical, Demographic, Familial, and Psychosocial Correlates
Arch Gen Psychiatry, March 1, 1986; 43(3): 234 - 244.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
N. C. Andreasen, W. Scheftner, T. Reich, R. M. A. Hirschfeld, J. Endicott, and M. B. Keller
The Validation of the Concept of Endogenous Depression: A Family Study Approach
Arch Gen Psychiatry, March 1, 1986; 43(3): 246 - 251.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
R. C. Casper, D. E. Redmond Jr, M. M. Katz, C. B. Schaffer, J. M. Davis, and S. H. Koslow
Somatic Symptoms in Primary Affective Disorder: Presence and Relationship to the Classification of Depression
Arch Gen Psychiatry, November 1, 1985; 42(11): 1098 - 1104.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
R. Kellner
Functional Somatic Symptoms and Hypochondriasis: A Survey of Empirical Studies
Arch Gen Psychiatry, August 1, 1985; 42(8): 821 - 833.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
J. F. Leckman, K. A. Caruso, B. A. Prusoff, M. M. Weissman, K. R. Merikangas, and D. L. Pauls
Appetite Disturbance and Excessive Guilt in Major Depression: Use of Family Study Data to Define Depressive Subtypes
Arch Gen Psychiatry, September 1, 1984; 41(9): 839 - 844.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
J. Davidson, C. Turnbull, R. Strickland, and M. Belyea
Comparative Diagnostic Criteria for Melancholia and Endogenous Depression
Arch Gen Psychiatry, May 1, 1984; 41(5): 506 - 511.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
E. S. Paykel, P. R. Rowan, R. R. Parker, and A. V. Bhat
Response to Phenelzine and Amitriptyline in Subtypes of Outpatient Depression
Arch Gen Psychiatry, September 1, 1982; 39(9): 1041 - 1049.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
C. L. Ravaris, D. S. Robinppson, J. O. Ives, A. Nies, and D. Bartlett
Phenelzine and Amitriptyline in the Treatment of Depression: A Comparison of Present and Past Studies
Arch Gen Psychiatry, September 1, 1980; 37(9): 1075 - 1080.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
J. R. T. Davidson, M. N. McLeod, C. D. Turnbull, H. L. White, and E. J. Feuer
Platelet Monoamine Oxidase Activity and the Classification of Depression
Arch Gen Psychiatry, July 1, 1980; 37(7): 771 - 773.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
J. C. Nelson and D. S. Charney
Primary Affective Disorder Criteria and the Endogenous-Reactive Distinction
Arch Gen Psychiatry, July 1, 1980; 37(7): 787 - 793.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
D. S. Robinson, A. Nies, C. L. Ravaris, J. O. Ives, and D. Bartlett
Clinical Pharmacology of Phenelzine
Arch Gen Psychiatry, May 1, 1978; 35(5): 629 - 635.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
J. Davidson, M. McLeod, B. Law-Yone, and M. Linnoila
A Comparison of Electroconvulsive Therapy and Combined Phenelzine-Amitriptyline in Refractory Depression
Arch Gen Psychiatry, May 1, 1978; 35(5): 639 - 642.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
P. E. Garfinkel, J. J. Warsh, H. C. Stancer, and D. D. Godse
CNS Monoamine Metabolism in Bipolar Affective Disorder: Evaluation Using a Peripheral Decarboxylase Inhibitor
Arch Gen Psychiatry, June 1, 1977; 34(6): 735 - 739.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
E. Robins, K. A. Gentry, R. A. Munoz, and S. Marten
A Contrast of the Three More Common Illnesses With the Ten Less Common in a Study and 18-Month Follow-up of 314 Psychiatric Emergency Room Patients: II. Characteristics of Patients With the Three More Common Illnesses
Arch Gen Psychiatry, March 1, 1977; 34(3): 269 - 281.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
D. E. Sternberg and M. E. Jarvik
Memory Functions in Depression: Improvement With Antidepressant Medication
Arch Gen Psychiatry, February 1, 1976; 33(2): 219 - 224.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
W. W. K. Zung
From Art to Science: The Diagnosis and Treatment of Depression
Arch Gen Psychiatry, September 1, 1973; 29(3): 328 - 337.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
D. S. Robinson, A. Nies, C. L. Ravaris, and K. R. Lamborn
The Monoamine Oxidase Inhibitor, Phenelzine, in the Treatment of Depressive-Anxiety States: A Controlled Clinical Trial
Arch Gen Psychiatry, September 1, 1973; 29(3): 407 - 413.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
M. D. Blumenthal
Heterogeneity and Research on Depressive Disorders
Arch Gen Psychiatry, June 1, 1971; 24(6): 524 - 531.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
A. Raskin, J. G Schulterbrandt, N. Reatig, C. Chase, and J. J McKeon
Differential Response to Chlorpromazine, Imipramine, and Placebo: A Study of Subgroups of Hospitalized Depressed Patients
Arch Gen Psychiatry, August 1, 1970; 23(2): 164 - 173.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
E. S. Paykel, G. L. Klerman, and B. A. Prusoff
Treatment Setting and Clinical Depression
Arch Gen Psychiatry, January 1, 1970; 22(1): 11 - 21.
[Abstract] [PDF]